$CUE 4 SEC Filings

Filed On	Filing
14 Oct 2026	Form 4: Meluzio Michael Vincent, VP, Prin. Accounting Officer Sold 1,144 shares ($32.1K)
14 Oct 2026	Form 4: Lin Shao-Lee, Director Sold 11,087 shares ($305K)
14 Oct 2026	Form 4: Ray Sumita, Chief Legal Compliance Officer Sold 1,844 shares ($51.7K)
17 Aug 2026	Form 4: Ray Sumita, Chief Legal Compliance Officer Received 18,196 shares by exercise or conversion · Sold 8,829 shares ($266K)
17 Aug 2026	Form 4: Meluzio Michael Vincent, VP, Prin. Accounting Officer Received 13,647 shares by exercise or conversion · Sold 5,628 shares ($169K)
14 Aug 2026	Form 4: Lin Shao-Lee, Director Received 109,179 shares by exercise or conversion · Sold 40,000 shares ($1.08M) · Sold 18,258 shares ($523K)
03 Aug 2026	Form 4: Ahlers James M, Chief Financial Officer Received 25,500 shares as a grant or award · Granted 51,000 Stock Option (Right to Buy)
15 Jul 2026	Form 4: Borie Dominique Christian, Chief Medical Officer Received 31,500 shares as a grant or award · Granted 63,000 Stock Option (Right to Buy)
10 Jul 2026	Form 4: Sarraf Pasha, Director Received 21,800 shares as a grant or award
10 Jul 2026	Form 4: Garzone Pamela, Director Received 21,800 shares as a grant or award
10 Jul 2026	Form 4: Camardo Daniel A., Director Received 21,800 shares as a grant or award
10 Jul 2026	Form 4: Meehan Viola Mong, Director Received 21,800 shares as a grant or award
10 Jul 2026	Form 4: Meluzio Michael Vincent, VP, Prin. Accounting Officer Received 40,942 shares as a grant or award · Granted 40,942 Common Stock
10 Jul 2026	Form 4: Ray Sumita, Chief Legal Compliance Officer Received 54,589 shares as a grant or award · Granted 54,589 Common Stock
10 Jul 2026	Form 4: Lin Shao-Lee, Director Received 327,537 shares as a grant or award · Granted 327,537 Common Stock
08 Jun 2026	Form 4: Camardo Daniel A., Director Granted 1,626 Stock Option (Right to Buy)
03 Jun 2026	Form 4: Lin Shao-Lee, Director Acquired 90,906 Pre-Funded Warrants (Right to Buy) (Open Market Purchase) ($1M) · Acquired 45,453 Common Stock Warrants (Right to Buy) (Open Market Purchase)
02 Jun 2026	Form 4: Meehan Viola Mong, Director Granted 1,626 Stock Option (Right to Buy)
07 May 2026	Form 4: Lin Shao-Lee, Director Received 327,537 shares as a grant or award · Granted 655,074 Stock Option (right to buy)
10 Apr 2026	Form 4: Warren Lucinda, CHIEF BUSINESS OFFICER Granted 250,000 Stock Option (right to buy)

Comments